4株猪链球菌2型分离株主要毒力因子（MRP、EF）的全基因序列分析

江苏农科院兽医研究所与南京农业大学倪艳秀、段志涛、何孔旺和陆承平等4位牧医研究工作者选取的猪链球菌2型（SS）是一种重要的人畜共患病病源菌,其中溶菌酶释放蛋白（MRP）和胞外因子（EF）是其重要的2种毒力因子。他们参照GenBank上发表的MRP和EF基因序列设计引物,对4株国内SS2分离株进行MRP和EF全基因序列测定并进行分析。结果表明,4株SS2国内分离株MRP基因的完整开放阅读框（ORF）都为3711bp、     

猪链球菌2型mrp基因免疫功能片段的克隆、表达及动物试验

根据猪链球菌2型（Streptococcus suis type 2）国外分离株的溶菌酶释放蛋白（Muramidasereleased protein, MRP）的基因序列,设计并合成一对引物,利用PCR技术扩增了江苏分离株的开放阅读框298～827bp间529bp的基因片段,并定向克隆至pET32a(+)表达载体中。重组质粒经限制性酶切鉴定和测序,转化至大肠杆菌BL21,经IPTG诱导,可表达分子量约42kD的蛋白。经过镍亲和层析柱层析,获得纯化的重组蛋白。以重组蛋白免疫Balb/c小鼠,以5LD50猪链球菌强毒株攻击后小鼠的相对存活率达625%。证实所表达的MRP片段为重要的保护性抗原。     

猪链球菌口服疫苗的制备及小鼠血清免疫效果的评价

为构建猪链球菌(Streptococcus suis)新型疫苗,给猪链球菌病的防治提供新思路,首先在大肠杆菌中表达猪链球菌毒力因子EF和MRP,以His-tag柱纯化重组蛋白,并制备EF和MRP鼠源多克隆抗体.随后将ef和mrp基因置于组成型启动子P59和信号肽Usp45下,克隆到乳酸菌表达载体pMG36e上,电击转化到干酪乳杆菌(Lactobacillus casei)ATCC27092中进行表达.Western blot 检测显示EF和MRP蛋白均能在乳酸菌中成功表达,且EF蛋白的表达量随着重组菌生长时间的增长而增大,而MRP蛋白的表达量在重组菌生长到OD600为0.8时达到最高,随后慢慢下降.用含有表达EF和MRP蛋白的重组干酪乳杆菌喂饲C57BL/6J小鼠,发现重组菌可在小鼠体内存活2d左右,并可有效刺激小鼠产生EF和MRP特异性抗体,为研制乳酸菌口服疫苗防治猪链球菌病的可行性进行了有益的探索.     

猪链球菌2型对扁桃腺上皮细胞的黏附和侵袭作用

猪链球菌2型(SS2)是重要的人畜共患病病原体,溶菌酶释放蛋白（MRP）是SS2的主要毒力因子之一。用天然表达MRP的江苏分离株HA9801和不表达MRP的上海分离株SH006444,研究SS2对仔兔扁桃腺上皮细胞的黏附和侵袭作用。黏附计数结果表明,HA9801（MRP+）和SH006444（MRP-）均能对扁桃腺上皮细胞高水平黏附。扫描和透射电镜均观察到HA9801的高水平黏附现象,黏附部位是细胞膜和细胞微绒毛,并观察到细胞膜上有链球菌正处于内化过程中。裂解记数结果表明,HA9801有低度侵袭力,SH006444未检测到侵袭力。结果提示,扁桃腺是SS2的定殖器官和感染门户;MRP＋菌株黏附后直接侵入细胞内是其穿过扁桃腺上皮细胞屏障的机制之一。     

猪链球菌2型新的感染相关因子自溶素的鉴定与分析

根据Sanger研究所公布的猪链球菌2型(SS2)P1/7株的自溶素序列,设计检测引物,取SS2我国2次流行株、其它临床分离株和参考株,及猪链球菌1型、1/2型、7型和9型,共33株,分别以其DNA为模板,PCR扩增.结果表明,SS2除无毒株T15阴性外,其他临床分离株27株(含人源2株)均阳性;其它猪链球菌为,SS7阳性,SS1、SS1/2和SS9均阴性.同时设计引物向两侧扩增,以四川流行株ZY05719和江苏流行株HA9801的DNA为模板,扩增自溶素ORF完整的编码基因,软件分析结果显示,该基因含有6个重复的"GBS_Bsp-like"域和1个"N-乙酰胞壁酰-L-丙氨酸酰胺酶"域,与SS2欧洲株有较高同源性(99.8%),但与SS2加拿大株差异较大.在DNASTAR分析所编码蛋白的抗原性的基础上,另设计引物,以ZY05719株DNA为模板,PCR扩增具有良好免疫原性的片段基因,并定向克隆至表达载体pET30a( )中,进行重组表达,SDS-PAGE和Western blot表明,所获得重组自溶素具有良好反应原性.     

猪链球菌2型的致病机制

猪链球菌2型是重要的人兽共患传染病病原。通常认为该菌的毒力因子与荚膜多糖(CPS)、溶菌酶释放蛋白(MRP)、细胞外因子(EF)和溶血素(SLY)等有关。该文介绍2型猪链球菌的感染途径、侵袭和黏附机制,以及对机体产生细胞因子的影响等。     

体内表达新基因trag在猪链球菌的分布及其免疫反应性分析

【目的】trag(transfer gene G)是利用IVIAT(in vivo induced antigen technology)通量筛选鉴定的猪链球菌2型（Streptococcus suis type 2,SS2）感染相关因子,研究该基因在猪链球菌（Streptococcus suis,SS）中的分布情况,研究康复血清与免疫血清在免疫印迹中的反应性有无,间接证明其在体内感染与体外培养时表达差异。【方法】鉴于我国分离株trag与GenBank公布的SS2北美株89/1591的trag序列有95.8%的同源性,据此设计和合成一对检测引物,对SS2我国江苏及四川流行株、其他临床分离株和参考株及SS1、SS1/2、SS9、SS7及C群猪源链球菌共43株进行PCR扩增。另设计一对引物,扩增5株SS代表菌株trag的完整阅读框,并对扩增产物进行测序。据软件分析后,选择TRAG(Transfer protein G?)免疫原性良好的区域片段的核酸设计表达引物,PCR扩增后定向克隆至表达载体pET28a(+)构建表达质粒,表达蛋白转印到PVDF膜上,分别与SS2猪康复血清和猪高免血清反应。【结果】trag在SS2中94%(30/32)阳性,SS9中67%(4/6)阳性,SS7阳性,SS1、SS1/2及C群菌阴性。5株细菌TRAG的氨基酸序列与SS2中国株98HAH33、05ZYH33及北美株89/1591同源性>97%。所获得重组蛋白只能被康复血清识别。【结论】从SS 致病株中检出感染相关基因trag,提示该基因可能与SS 致病性有关,重组蛋白的免疫转印结果表明,TRAG可能与SS2体内感染相关。     

应用聚合酶链式反应快速特异鉴定假单胞菌和伯克霍尔德氏菌（R）-3-羟基酯酰载酯蛋白-辅酶A转酰基酶基因

聚羟基脂肪酸酯 (PHA)是一类具有广泛应用前景的可降解生物塑料。因其可以以葡萄糖等廉价底物直接发酵生产PHA而日益受到重视。目前的研究表明在积累中长链PHA的假单胞菌中 ,由phaG基因编码的（R）3 羟基酯酰载酯蛋白 辅酶A转酰基酶 (PhaG)起关键作用 ,但目前为止对该蛋白还知之甚少。通过聚合酶链式反应 (PCR)建立了一种快速、特异鉴定phaG基因的方法 ,应用该方法成功地从两株积累不同PHA的假单胞菌Pseudomonasstutzeri 1317和Pseudomonasnitroreducens 080 2中分别克隆得到phaG基因 ,并在phaG基因突变株PseudomonasputidaPHAG_N-21中表达成功。同时 ,还首次报道了从非假单胞菌菌株Burkholderiacaryophylli AS 1.274 1中鉴定得到phaG基因 ,提示PhaG介导的中长链PHA合成途径作为一种通用的代谢模式在细菌中广泛存在 ,为进一步实现从廉价的非相关底物合成中长链PHA提供了必要的分子生物学基础。     

椰毒假单胞菌的电镜观察

酵米面假单胞菌(Pseudomonas farinofermentans)系从食物中毒的变质酵米面中分离到的病原菌,它与揶毒假单胞菌(P.cocovenenans)为同种不同生物型,与洋葱假单胞菌(P.cepaia)有许多共同点。电镜观察表明,此3株假单胞菌在形态和结构上有以下共同特点：菌体呈短杆状,0．6-0．8×1．5—2．0μm。细胞壁由肽聚糖层和外膜(outer membrane)构成。有时可见丝状体(filaments) 甚至畸形细胞。无荚膜,无菌毛(pili)一端有多根鞭毛。细胞质内有电子透明的聚β-羟基丁酸盐(PHB)颗粒。核区内有电子致密体(e|ectron-densebodies)或层状体(laminar bodies)。细胞表面可见到wei7细胞(mlncells)。均能产生细胞外“丝状物质”,这一特点尚未见报道。     

人源中和性抗高致病性禽流感病毒H5N1基因工程全抗体的研制

运用噬菌体表面呈现技术,从禽流感病人恢复期血中获得淋巴细胞,通过基因工程手段,构建了人源抗H5NI禽流感病毒基因工程抗体文库.用纯化的人源H5N1禽流感病毒颗粒(A/Anhui/1/2005)及重组血凝素蛋白HA(A/Viet Nam/1203/2004)对Fab噬菌体抗体库进行富集筛选,成功地获得了抗禽流感病毒H5N1血凝素蛋白HA的人源单抗Fab段基因,并在大肠杆菌中获得有效表达.通过序列测定确定抗体轻重链型别,然后将阳性克隆的轻链和重链Fd段基因分别克隆入全抗体表达载体pAC-L-Fc后转染昆虫Sf9细胞,利用杆状病毒/昆虫细胞系统实现全抗体的分泌型表达.用ELISA、IFA和流式细胞术对所获人源单抗的功能特性进行鉴定.结果表明,我们获得了2株特异性针对H5N1禽流感病毒血凝素蛋白HA而与甲1型和甲3型人流感病毒无交叉反应的人源单抗(AVFlulgG01、AVFlulgG03).微量中和试验结果表明,除A/Guangdong/1/2006外,AVFlu-IgG01能够广泛地中和HA基因进化上属于Clade 2的中国南方、北方及中部地区的H5N1禽流感病毒分离株,同时还对属于Clade Ⅰ的越南H5N1分离株A/Viet Nam/1203/2004具有中和活性;AVFluIgG03虽然不能中和A/Viet Nam/1203/2004,但是对属于Clade 2的所有中国H5N1分离株均具有中和作用.人源中和性抗禽流感病毒H5N1基因工程全抗体的获得不仅为高致病性禽流感病毒H5N1的预防和治疗带来了希望,同时也为其疫苗研制提供了新的思路.     

Differences in the population structure of invasive Streptococcus suis strains isolated from pigs and from humans in The Netherlands

Streptococcus suis serotype 2 is the main cause of zoonotic S. suis infection despite the fact that other serotypes are frequently isolated from diseased pigs. Studies comparing concurrent invasive human and pig isolates from a single geographical location are lacking. We compared the population structures of invasive S. suis strains isolated between 1986 and 2008 from human patients (N?=?24) and from pigs with invasive disease (N?=?124) in The Netherlands by serotyping and multi locus sequence typing (MLST). Fifty-six percent of pig isolates were of serotype 9 belonging to 15 clonal complexes (CCs) or singleton sequence types (ST). In contrast, all human isolates were of serotype 2 and belonged to two non-overlapping clonal complexes CC1 (58%) and CC20 (42%). The proportion of serotype 2 isolates among S. suis strains isolated from humans was significantly higher than among strains isolated from pigs (24/24 vs. 29/124; P<0.0001). This difference remained significant when only strains within CC1 and CC20 were considered (24/24 vs. 27/37,P?=?0.004). The Simpson diversity index of the S. suis population isolated from humans (0.598) was smaller than of the population isolated from pigs (0.765, P?=?0.05) indicating that the S. suis population isolated from infected pigs was more diverse than the S. suis population isolated from human patients. S. suis serotype 2 strains of CC20 were all negative in a PCR for detection of genes encoding extracellular protein factor (EF) variants. These data indicate that the polysaccharide capsule is an important correlate of human S. suis infection, irrespective of the ST and EF encoding gene type of S. suis strains.     

Identification of immunogenic cell wall-associated proteins of Streptococcus suis serotype 2

Streptococcus suis serotype 2 (SS2) is a porcine and human pathogen with adhesive and invasive properties. The absence of suitable vaccine or virulent marker can be the bottleneck to control SS2 infection. An immunoproteome-based approach was developed to identify candidate antigens of SS2 for vaccine development. Hyperimmune sera, convalescent sera, and control sera were analyzed for reactivity by Western Blot against SS2 cell wall-associated proteins (WAPs) separated by 2-DE. A total of 34 proteins were identified by immunoproteomic analysis, of which 15 were recognized by both hyperimmune sera and convalescent sera, including most WAPs currently characterized as SS2 vaccine candidate antigens: muramidase-released protein (MRP), surface protein SP1 (Sao), and glyceraldehyde-3-phosphate dehydrogenase (GapdH). The novel immunogenic proteins may be developed as alternative antigens for further study of SS2 vaccine and diagnostics.     

Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2

Streptococcus suis, a zoonotic pathogen, caused serious outbreaks in humans with high mortality rates in the past decade. To develop safer and more effective vaccines, particularly for human protection, cell wall and extracellular proteins of S. suis serotype 2 were analyzed by an immunoproteomic approach in this study. Thirty-two proteins with high immunogenicity were identified and 22 of them were newly identified. Further analyses of 9 selected proteins revealed that (1) these 9 proteins were expressed in all tested virulent S. suis serotype 2 isolates, (2) antisera against 6 of the selected proteins efficiently killed the bacteria by opsonized phagocytosis in human blood, and (3) significantly higher levels of serum antibodies against 3 proteins were detected in both patients and infected swines. Therefore, our results suggest the 3 proteins (SSU98_0197, SSU98_1094 and SSU1664) have strong potential to be vaccine candidates.     

Immunoproteomics of extracellular proteins of Chinese virulent strains of Streptococcus suis type 2

Streptococcus suis type 2 (SS2) is a porcine zoonotic pathogen with worldwide distribution, and lacking suitable vaccine and virulent maker were bottleneck to control this infection. An immunoproteomic assay was used to identify antigenic proteins from the total extracellular proteins of the virulent Chinese SS2 strain ZY05719. The convalescent serum of a specific pathogen free (SPF) mini-pig recognized nine protein spots on PVDF membrane. Antigenic proteins on a duplicate gel, as well as those with a similar placement of extracellular proteins from another virulent strain (HA9801) and an avirulent strain (T15) on 2-D gels, were excised and identified by MALDI-TOF-MS. PMF of the protein spots were performed using the MASCOT server. Two proteins were found in all three strains. Comparative proteomic analysis between the two virulent strains and the avirulent strain revealed nine differential proteins, eight of which were successfully identified. Genes for six of the differentially expressed proteins were found in both virulent strains, and of those were present in the avirulent stain.     

猪链球菌2型溶菌酶释放蛋白诱导上皮细胞融合和凋亡

猪链球菌2型（SS2）溶菌酶释放蛋白(MRP)的致病作用迄今不明,为此,以Hep2细胞为上皮细胞体外模型,将纯化的MRP溶液和细胞共孵育,光镜观察,发现MRP可诱导细胞发生两种典型形态学变化：一是诱导细胞融合形成多核巨细胞,随后巨细胞发生凋亡;二是诱导单个细胞凋亡。透射电镜观察和流式细胞分析确证MRP具有诱导上皮细胞凋亡的功能,凋亡率达18%。证明MRP可单独作为SS2的毒力因子。     

猪链球菌2型荚膜唾液酸对细菌毒力和宿主炎症反应的影响

【目的】阐明猪链球菌2型荚膜唾液酸是否影响细菌毒力以及宿主对其炎症反应应答,为研究猪链球菌2型的致病机制奠定基础。【方法】比较实验菌株对BLAB/c小鼠模型的致病性;通过涂板计数的方法检测实验菌株在小鼠体内的分布;观察小鼠脑组织病理改变,分析实验菌株感染小鼠后中枢神经系统的病变差异;从小鼠体外全血细胞水平,运用ELISA法检测实验菌株感染后细胞炎性因子的分泌水平。【结果】荚膜唾液酸合成基因neuB缺失突变株ΔneuB相比野生株05ZYH33株,对小鼠毒力显著降低,回复突变株cΔneuB毒力回复至野生株水平;野生株和突变株在血液及脑组织中分布具有显著差异,均可致BLAB/c小鼠脑组织不同程度的损伤;与野生株组相比较,细菌/细胞相互作用不同时间点后,突变株组体外刺激小鼠全血细胞分泌MCP-1、IL-6的水平显著提高;【结论】荚膜唾液酸影响细菌的毒力及宿主细胞对其的炎症反应应答,它是猪链球菌2型穿透血脑屏障导致脑膜炎的重要毒力因子。     

Prevalence of Streptococcus suis genotypes in wild boars of Northwestern Germany

Invasive serotype 2 (cps2+) strains of Streptococcus suis cause meningitis in pigs and humans. Four case reports of S. suis meningitis in hunters suggest transmission of S. suis through the butchering of wild boars. Therefore, the objective of this study was to investigate the prevalence of potentially human-pathogenic S. suis strains in wild boars. S. suis was isolated from 92% of all tested tonsils (n=200) from wild boars. A total of 244 S. suis isolates were genotyped using PCR assays for the detection of serotype-specific genes, the hemolysin gene sly, and the virulence-associated genes mrp and epf. The prevalence of the cps2+ genotype among strains from wild boars was comparable to that of control strains from domestic pig carriers. Ninety-five percent of the cps2+ wild boar strains were positive for mrp, sly, and epf*, the large variant of epf. Interestingly, epf* was significantly more frequently detected in cps2+ strains from wild boars than in those from domestic pigs; epf* is also typically found in European S. suis isolates from humans, including a meningitis isolate from a German hunter. These results suggest that at least 10% of wild boars in Northwestern Germany carry S. suis strains that are potentially virulent in humans. Additional amplified fragment length polymorphism analysis supported this hypothesis, since homogeneous clustering of the epf* mrp+ sly+ cps2+ strains from wild boars with invasive human and porcine strains was observed.     

Immunoproteomic assay of surface proteins of Streptococcus suis serotype 9

Streptococcus suis is an important swine pathogen responsible for a diverse group of diseases. Studies on vaccines have focused on S. suis serotype 2 strains, which are the most invasive isolates worldwide. However, in China S. suis serotype 9 (SS9) is also a prevalent serotype, which is frequently isolated from diseased pigs. Little is known about immunogenic proteins for SS9. Therefore, an immunoproteomic-based approach was developed to identify immunogenic proteins of SS9. Cell wall proteins extracted from SS9 strain GZ0565 isolated from a diseased pig with meningitis were screened by two-dimensional Western blotting using anti-SS9 sera pooled from specific pathogen-free mice. Protein spots were excised from preparative gels and identified by matrix-assisted laser desorption ionization time-of-flight MS (MALDI-TOF-MS) or MALDI-TOF-TOF-MS, which led to the identification of eight immunogenic proteins (arginine deiminase, extracellular solute-binding protein, translation elongation factor Ts, neprilysin, peptide ATP-binding cassette transporter peptide-binding protein, pyruvate kinase, phosphate acetyltransferase, and fructose-bisphosphate aldolase). These immunogenic proteins, which are encoded by genes that are reasonably conserved among SS9 strains, could be developed as vaccine candidates.     

Genetic analysis of the capsular polysaccharide synthesis locus in 15 Streptococcus suis serotypes

The capsular polysaccharide (CPS) synthesis locus of 13 Streptococcus suis serotypes (serotype 1, 3, 4, 5, 7, 8, 9, 10, 14, 19, 23, 25 and 1/2) was sequenced and compared with that of serotype 2 and 16. The CPS synthesis locus of these 15 serotypes falls into two genetic groups. The locus is located on the chromosome between orfZ and aroA. All the translated proteins in the CPS synthesis locus were clustered into 127 homology groups using the tribemcl algorithm. The general organization of the locus suggested that the CPS of S.?suis could be synthesized by the Wzy-dependent pathway. The capsule of serotypes 3, 4, 5, 7, 9, 10, 19 and 23 was predicted to be amino-polysaccharide. Sialic acid was predicted to be present in the capsule of serotypes 1, 2, 14, 16 and 1/2. The characteristics of the CPS synthesis locus suggest that some genes may have been imported into S.?suis (or their ancestors) on multiple occasions from different and unknown sources.     

Streptococcus Suis Isolated from Pigs in Finland

A total of 58 Streptococcus suis strains were isolated from deceased pigs submitted to the National Veterinary Institute, Regional Laboratory in Kuopio, Finland, over a 3 1/2 year period, most frequently from cases of pneumonia. The bacteria were isolated from cases of meningitis, sepsis, rhinitis, endocarditis and abortion. S. suis was also isolated from nasal cavity, lung and brain of some sick piglets without signs of inflammation. Further S. suis was detected in 12 out of 107 tonsils of healthy fatteners tested. S. suis strains were identified by biochemical methods followed by typing. The most common capsular types were 7, 3 and 2, respectively. Only one type 1 strain and no types 6 and 9 strains were found. All S. suis strains tested were sensitive to penicillin and ampicillin. S. suis is not uncommon in Finnish pig herds. S. suis may be regarded as a potentially pathogenic organism which under certain predisposing conditions may cause serious disease.